Eiger BioPharma: 4Q Earnings Snapshot

March 13, 2020 GMT

PALO ALTO, Calif. (AP) _ Eiger BioPharmaceuticals Inc. (EIGR) on Friday reported a loss of $16.9 million in its fourth quarter.

On a per-share basis, the Palo Alto, California-based company said it had a loss of 69 cents.

For the year, the company reported that its loss widened to $70.3 million, or $3.08 per share.

Eiger BioPharma shares have decreased 62% since the beginning of the year. The stock has fallen 58% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EIGR at https://www.zacks.com/ap/EIGR